Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-26 @ 3:34 AM
Study NCT ID:
NCT05414318
Status:
COMPLETED
Last Update Posted:
2024-10-03
First Post:
2022-06-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Sponsor:
W.L.Gore & Associates
Organization:
Study Overview
Official Title:
Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis (CTAG)
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: